Systemic Allergic Reaction to SARS-CoV-2 Vaccination Request More Information Trial Objective This research is being done to determine whether highly allergic people or people with mast cell disorders (a buildup of the white blood cells that release substances causing symptoms similar to an allergic reaction) are more likely to have an allergic reaction to the new Pfizer-BioNTech and Moderna COVID-19 vaccines than other people. We would also like to understand why some people have allergic reactions to these vaccines. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate Individuals who are 12 to 69 years of age and either have a history of serious allergic reaction, have a mast cell disorder, or have no allergies at all. Age: Not Specified Gender: Any Gender Estimated Time Commitment Not Specified × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Ashley Kohlhepp 303.270.2145 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors National Institute of Allergy and Infectious Disease (NIAID) Principal Investigators Donald Leung, PhD, MD + × Donald Leung, PhD, MD Professor Head, Division of Pediatric Allergy & Immunology Department of Pediatrics View Full Profile Make an Appoinment Co-Investigators Anna Meyer, MD, PhD + × Anna Meyer, MD, PhD Assistant Professor Division of Pediatric Allergy & Clinical Immunology Department of Pediatrics View Full Profile Make an Appoinment Bruce Lanser, MD, MPH + × Bruce Lanser, MD, MPH Assistant Professor Director, Pediatric Food Allergy Program Director, Pediatric Allergy Fellowship Program Department of Pediatrics Division of Allergy & Clinical Immunology View Full Profile Patient Rating 4.6 out of 5 stars Make an Appoinment Carah Santos, MD + × Carah Santos, MD Assistant Professor Division of Pediatric Allergy & Clinical Immunology Department of Pediatrics Division of Allergy & Clinical Immunology Department of Medicine View Full Profile Make an Appoinment Flavia Hoyte, MD + × Flavia Hoyte, MD Associate Professor Director, Allergy & Clinical Immunology Fellowship Department of Medicine Division of Allergy & Clinical Immunology View Full Profile Patient Rating 4.8 out of 5 stars Make an Appoinment Jessica Hui, MD + × Jessica Hui, MD Department of Pediatrics View Full Profile Make an Appoinment Mark Boguniewicz, MD + × Mark Boguniewicz, MD Professor Division of Pediatric Allergy & Clinical Immunology Department of Pediatrics View Full Profile Patient Rating 4.5 out of 5 stars Make an Appoinment Request More Information By completing this form, you agree to learn more about this study and see if you qualify. First Name:* Last Name:* Email Address:* Phone:* I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: YesNo
Trial Objective This research is being done to determine whether highly allergic people or people with mast cell disorders (a buildup of the white blood cells that release substances causing symptoms similar to an allergic reaction) are more likely to have an allergic reaction to the new Pfizer-BioNTech and Moderna COVID-19 vaccines than other people. We would also like to understand why some people have allergic reactions to these vaccines.